A Randomized, Double-Blind, Parallel Group Clinical Study to Evaluate the Efficacy and Safety of an Ayurvedic formulation (Slim MetS) in patients with Metabolic Syndrome (MetS)

Desh Bhagat University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•Male and Female 18-65 aged, with diagnosis of metabolic syndrome, defined by the presence of waist circumference > 102 cm (M) or >88 cm (F), and two or more of these criteria:
•1. fasting blood glucose >100 mg;
•2. systolic blood pressure >135 or diastolic blood pressure >85 mmHg
•3. triglyceridemia >150 mg/dl;
•4. HDL cholesterolemia < 40 mg/dl (M), < 50 mg/dl(F).
•5. Patient willing to participate in the study for 12 weeks.

•1. Patients with diabetes mellitus (FBS >126mg/dl);
•2. Patients with blood pressure more than 160/100 mmHg.
•3. Triglyceridemia > 500 mg/dl;
•4. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders etc).
•5. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia.
•6. Symptomatic patients with clinical evidence of heart failure, hepatic failure and renal failure (serum creatinine >2 mg/dl).
•7. Alcoholics and/or drug abusers.
•8. Pregnant and lactating mothers
•9. Any other condition which the Investigator thinks may jeopardize the study.

发起方